• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“心房颤动优化治疗(ABC)路径”与服用维生素K拮抗剂的心房颤动患者抗凝质量的关系

Relation of the 'Atrial Fibrillation Better Care (ABC) Pathway' to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists.

作者信息

Roldán Vanessa, Martínez-Montesinos Lorena, López-Gálvez Raquel, García-Tomás Lucía, Lip Gregory Y H, Rivera-Caravaca José Miguel, Marín Francisco

机构信息

Department of Hematology and Clinical Oncology, Hospital General Universitario Morales Meseguer, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), 30008 Murcia, Spain.

Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, 30120 Murcia, Spain.

出版信息

J Pers Med. 2022 Mar 17;12(3):487. doi: 10.3390/jpm12030487.

DOI:10.3390/jpm12030487
PMID:35330486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8954236/
Abstract

The Atrial Fibrillation Better Care (ABC) pathway was proposed for a more integrated atrial fibrillation (AF) care. We investigated if adherence to the ABC pathway was associated to the quality of anticoagulation control in a cohort of AF outpatients starting vitamin K antagonists (VKAs) between July 2016 and June 2018. Patients were considered adherent to the ABC pathway if they met all of its components. The time in therapeutic range (TTR) was estimated at one year. In total, 1045 patients (51.6% female; median age 77 years; 63% ABC pathway adherent) were included. At one year, 474 (51.6%) of 919 patients with international normalized ratio (INR) data for TTR estimation had a TTR < 65%. Among ABC pathway non-adherent patients, a greater proportion had TRT < 65% (56.4% vs. 43.6%, p = 0.025), and TTR < 70% (64.9% vs. 35.1%, p = 0.033), with lower mean TTR in non-adherent patients (59.4 ± 22.3% vs. 63.9 ± 21.1%; p = 0.004). Logistic regression models demonstrated that the ABC pathway adherence in its continuous (aOR: 0.75, 95% CI 0.59−0.96) and categorical (aOR: 0.75, 95% CI 0.57−0.98) forms was independently associated with TTR ≥ 65%. In this ‘real-world’ cohort of AF patients starting VKAs, the ABC pathway adherent patients had better TTR, and more ABC criteria fulfilled increased the probability of achieving good TTR.

摘要

心房颤动优化治疗(ABC)路径旨在实现更综合的心房颤动(AF)护理。我们调查了在2016年7月至2018年6月期间开始使用维生素K拮抗剂(VKA)的AF门诊患者队列中,遵循ABC路径是否与抗凝控制质量相关。如果患者符合ABC路径的所有组成部分,则被视为遵循该路径。治疗范围内时间(TTR)在一年时进行估算。总共纳入了1045例患者(女性占51.6%;中位年龄77岁;63%遵循ABC路径)。一年时,在919例有国际标准化比值(INR)数据用于TTR估算的患者中,474例(51.6%)的TTR<65%。在未遵循ABC路径的患者中,更大比例的患者TRT<65%(56.4%对43.6%,p = 0.025),且TTR<70%(64.9%对35.1%,p = 0.033),未遵循路径的患者平均TTR较低(59.4±22.3%对63.9±21.1%;p = 0.004)。逻辑回归模型表明,ABC路径的连续形式(调整后比值比:0.75,95%置信区间0.59 - 0.96)和分类形式(调整后比值比:0.75,95%置信区间0.57 - 0.98)均与TTR≥65%独立相关。在这个开始使用VKA的AF患者“真实世界”队列中,遵循ABC路径的患者TTR更佳,满足更多ABC标准增加了实现良好TTR的概率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0277/8954236/2d82e9096e36/jpm-12-00487-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0277/8954236/f518310aba6a/jpm-12-00487-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0277/8954236/587b35e8c61f/jpm-12-00487-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0277/8954236/2d82e9096e36/jpm-12-00487-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0277/8954236/f518310aba6a/jpm-12-00487-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0277/8954236/587b35e8c61f/jpm-12-00487-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0277/8954236/2d82e9096e36/jpm-12-00487-g003.jpg

相似文献

1
Relation of the 'Atrial Fibrillation Better Care (ABC) Pathway' to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists.“心房颤动优化治疗(ABC)路径”与服用维生素K拮抗剂的心房颤动患者抗凝质量的关系
J Pers Med. 2022 Mar 17;12(3):487. doi: 10.3390/jpm12030487.
2
The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort.心房颤动的更好护理(ABC)途径和心房颤动患者的临床结局:前瞻性穆尔西亚房颤项目二期队列研究。
J Gen Intern Med. 2023 Feb;38(2):315-323. doi: 10.1007/s11606-022-07567-5. Epub 2022 Apr 11.
3
Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry.综合护理管理对心房颤动患者临床结局的影响:来自FANTASIIA注册研究的报告
Front Cardiovasc Med. 2022 May 2;9:856222. doi: 10.3389/fcvm.2022.856222. eCollection 2022.
4
Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry.影响新使用维生素 K 拮抗剂的房颤患者抗凝质量的因素:来自全国和多中心 SULTAN 登记研究的见解。
Europace. 2022 Jan 4;24(1):4-11. doi: 10.1093/europace/euab131.
5
Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation.心房颤动优化照护路径依从性照护可改善中国心房颤动患者的结局。
JACC Asia. 2022 Apr 26;2(4):422-429. doi: 10.1016/j.jacasi.2022.01.007. eCollection 2022 Aug.
6
Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.维生素 K 拮抗剂控制质量与心房颤动患者结局的关系:一项荟萃分析和荟萃回归。
Thromb J. 2014 Jun 24;12:14. doi: 10.1186/1477-9560-12-14. eCollection 2014.
7
Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry.欧洲心房颤动患者结局与 ABC(心房颤动更好护理)路径依从性护理的关系:ESC-EHRA EORP 心房颤动一般长期(AFGen LT)登记处的分析。
Europace. 2021 Feb 5;23(2):174-183. doi: 10.1093/europace/euaa274.
8
Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Treated With Vitamin K Antagonists by Hemostasis Specialists: The TERRA Registry: Tiempo en rango en la República Argentina.止血专家对接受维生素K拮抗剂治疗的心房颤动患者的慢性抗凝控制质量及在治疗范围内的时间进行评估:TERRA注册研究:阿根廷共和国的目标时间范围。
Clin Appl Thromb Hemost. 2017 Jul;23(5):445-453. doi: 10.1177/1076029615623378. Epub 2016 Jan 5.
9
Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol.服用华法林的房颤患者治疗范围时间缩短和死亡率升高。
Clin Ther. 2018 Jan;40(1):114-122. doi: 10.1016/j.clinthera.2017.11.014. Epub 2017 Dec 21.
10
Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry.真实世界中房颤患者应用维生素 K 拮抗剂的口服抗凝治疗质量:来自前瞻性多中心 FANTASIIA 注册研究的报告。
Europace. 2018 Sep 1;20(9):1435-1441. doi: 10.1093/europace/eux314.

引用本文的文献

1
Progressions in Cardiac Arrhythmia: Specific Populations and the Need for Precision Medicine.心律失常的进展:特定人群与精准医学的需求
J Pers Med. 2023 Jul 11;13(7):1122. doi: 10.3390/jpm13071122.

本文引用的文献

1
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.2021 年亚太心律学会心房颤动卒中预防聚焦更新共识指南:执行摘要。
Thromb Haemost. 2022 Jan;122(1):20-47. doi: 10.1055/s-0041-1739411. Epub 2021 Nov 13.
2
The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review.心房颤动的更好护理途径管理心房颤动:综述。
Europace. 2021 Oct 9;23(10):1511-1527. doi: 10.1093/europace/euab092.
3
Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients.
房颤患者遵循“房颤优化管理路径”:对 28.5 万名患者临床结局的影响——系统评价和荟萃分析。
Thromb Haemost. 2022 Mar;122(3):406-414. doi: 10.1055/a-1515-9630. Epub 2021 Jun 21.
4
Integrated care for atrial fibrillation: the heart of the matter.心房颤动的综合治疗:问题的核心
Eur J Prev Cardiol. 2022 Nov 8;29(15):2058-2063. doi: 10.1093/eurjpc/zwaa065.
5
Direct oral anticoagulants: evidence and unresolved issues.直接口服抗凝剂:证据与未决问题。
Lancet. 2020 Nov 28;396(10264):1767-1776. doi: 10.1016/S0140-6736(20)32439-9.
6
Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry.欧洲心房颤动患者结局与 ABC(心房颤动更好护理)路径依从性护理的关系:ESC-EHRA EORP 心房颤动一般长期(AFGen LT)登记处的分析。
Europace. 2021 Feb 5;23(2):174-183. doi: 10.1093/europace/euaa274.
7
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
8
Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.21 世纪心房颤动的流行病学:新方法与新见解。
Circ Res. 2020 Jun 19;127(1):4-20. doi: 10.1161/CIRCRESAHA.120.316340. Epub 2020 Jun 18.
9
The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients: A Systematic Need for New Strategies.
Thromb Haemost. 2020 Mar;120(3):369-371. doi: 10.1055/s-0040-1702231. Epub 2020 Mar 5.
10
Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study.机械心脏瓣膜置换术后患者华法林抗凝治疗低质量的影响因素:全国性 PLECTRUM 研究。
Br J Haematol. 2020 Aug;190(4):588-593. doi: 10.1111/bjh.16528. Epub 2020 Feb 20.